🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Dimebon alone

Found 10 matching trials

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

PHASE1

This study will evaluate four different modified release formulation to est...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-10

Trial ID

NCT00988624

Treatments Being Tested

Dimebon IR Tablet Dimebon MR1 Dimebon MR2 Dimebon MR3 Dimebon MR4

A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan

PHASE1

This drug-drug interaction study is being conducted to evaluate the potenti...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2008-11

Trial ID

NCT00788047

Treatments Being Tested

Dextromethorphan Dimebon + Dextromethorphan

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

PHASE1

This study is to characterize the pharmacokinetics of single and multiple o...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-02

Trial ID

NCT00825084

Treatments Being Tested

Dimebon Dimebon Dimebon Dimebon

A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults

PHASE1

The purpose of this study is to evaluate the safety, tolerability and pharm...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-06

Trial ID

NCT00907322

Treatments Being Tested

Dimebon Dimebon Dimebon Dimebon

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

PHASE1

This study is to compare the pharmacokinetics of Dimebon in subjects with s...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-02

Trial ID

NCT00824590

Treatments Being Tested

Dimebon Dimebon

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

PHASE1

This study will evaluate the potential drug-drug interaction of Dimebon wit...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-02

Trial ID

NCT00827034

Treatments Being Tested

Warfarin Dimebon Warfarin

Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function

PHASE1

1. To compare the pharmacokinetics of Dimebon in subjects with mild and mod...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-02

Trial ID

NCT00831532

Treatments Being Tested

Dimebon Dimebon Dimebon Dimebon

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

PHASE1

To estimate the absorption, safety, and tolerability of a dimebon transderm...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-10

Trial ID

NCT00990613

Treatments Being Tested

Dimebon IR Dimebon Transdermal Dimebon Transdermal Dimebon IR Dimebon Transdermal

A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

PHASE1

This study will evaluate the potential for a drug-drug interaction of Dimeb...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-07

Trial ID

NCT00931073

Treatments Being Tested

Dimebon alone Dimebon + Ketoconazole Dimebon + Omeprazole

A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

PHASE1

Dimebon will not exhibit abuse potential when compared to placebo or a posi...

Status

Completed

Location

Multiple Locations

Start Date

2009-10

Trial ID

NCT00975481

Treatments Being Tested

dimebon dimebon dimebon placebo alprazolam alprazolam

Previous Next